BLUeaNT
About BLUeaNT
- Released
- Updated
- iOS Version
- Age Rating
- Size
- Devices
- Languages
Features
Developer of BLUeaNT
What's New in BLUeaNT
2.0.9
July 22, 2024
- Introduced Meetings Notes - Improved contact screen for AMFI due diligence req. - Improved NSE Onboarding Workflow - Added KYC Check while Placing Order - Added IIN Rejection Reason in Profiles - Added Google SDK 14 Support - Added Collapsable Option on Home & Portfolio - Added Transaction Mode in New Investment - Added Balance units on fund's detailed Screen - Resolved Mandates Listing & Date Issue - Resolved Date Related Issues - Resolved Capital Gain Realised Report Issue
MoreAlternatives to BLUeaNT
More Applications by Excel Net Solutions Private Limited
BLUeaNT FAQ
Can BLUeaNT support iPad devices?
Yes, BLUeaNT has support for iPad devices.
Who is the developer of BLUeaNT?
The BLUeaNT app was built by Excel Net Solutions Private Limited.
What’s the minimum iOS version supported by the BLUeaNT app?
BLUeaNT requires iOS 15.0 or later.
What is the overall user rating for BLUeaNT?
Currently, the BLUeaNT app has no user ratings.
What’s the app category of BLUeaNT?
The Main Genre Of The Blueant App Is Finance.
What is the latest version of BLUeaNT?
The latest BLUeaNT version released is 2.0.9.
What is the date of the latest BLUeaNT update?
The last update for BLUeaNT was on December 2, 2024.
When did the BLUeaNT app come out?
BLUeaNT was first released on February 5, 2023.
What is the age rating of BLUeaNT?
May contain some explicit language, nudity, or sexual content, appropriate for ages 17 and up.
What are the languages supported by BLUeaNT?
BLUeaNT is available in English.
Does Apple Arcade offer BLUeaNT as part of its collection?
No, BLUeaNT is not featured on Apple Arcade.
Can I make in-app purchases within BLUeaNT?
No, BLUeaNT does not include options for in-app purchases.
Can I use BLUeaNT with Apple Vision Pro?
No, you cannot use BLUeaNT with Apple Vision Pro.
Are there commercial ads in BLUeaNT?
No, there are no commercial ads in BLUeaNT.